搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Azorhizobium caulinodans Cytochrome c-type biogenesis protein CcmE (ccmE), partial CSB-YP426878DPR
CSB-EP426878DPR
CSB-BP426878DPR
CSB-MP426878DPR
CSB-EP426878DPR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Azorhizobium caulinodans 50S ribosomal protein L1 (rplA) CSB-YP426879DPR
CSB-EP426879DPR
CSB-BP426879DPR
CSB-MP426879DPR
CSB-EP426879DPR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Azorhizobium caulinodans UPF0060 membrane protein AZC_0909 (AZC_0909), partial CSB-YP426880DPR1
CSB-EP426880DPR1
CSB-BP426880DPR1
CSB-MP426880DPR1
CSB-EP426880DPR1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Azorhizobium caulinodans Probable DNA repair protein AZC_1005 (AZC_1005) CSB-YP426881DPR
CSB-EP426881DPR
CSB-BP426881DPR
CSB-MP426881DPR
CSB-EP426881DPR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Azorhizobium caulinodans Ribosomal RNA small subunit methyltransferase A (rsmA) CSB-YP426882DPR
CSB-EP426882DPR
CSB-BP426882DPR
CSB-MP426882DPR
CSB-EP426882DPR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Azorhizobium caulinodans Homoserine kinase (thrB) CSB-YP426883DPR
CSB-EP426883DPR
CSB-BP426883DPR
CSB-MP426883DPR
CSB-EP426883DPR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydomonas reinhardtii Intraflagellar transport protein 43 (IFT43) CSB-YP426884DSJ
CSB-EP426884DSJ
CSB-BP426884DSJ
CSB-MP426884DSJ
CSB-EP426884DSJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Azorhizobium caulinodans Phospho-N-acetylmuramoyl-pentapeptide-transferase (mraY), partial CSB-YP426885DPR
CSB-EP426885DPR
CSB-BP426885DPR
CSB-MP426885DPR
CSB-EP426885DPR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Azorhizobium caulinodans Phosphoenolpyruvate carboxylase (ppc), partial CSB-YP426886DPR
CSB-EP426886DPR
CSB-BP426886DPR
CSB-MP426886DPR
CSB-EP426886DPR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Hirudo medicinalis Theromacin CSB-YP426887HSM
CSB-EP426887HSM
CSB-BP426887HSM
CSB-MP426887HSM
CSB-EP426887HSM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Azorhizobium caulinodans tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG (mnmG), partial CSB-YP426888DPR
CSB-EP426888DPR
CSB-BP426888DPR
CSB-MP426888DPR
CSB-EP426888DPR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Azorhizobium caulinodans 30S ribosomal protein S2 (rpsB) CSB-YP426889DPR
CSB-EP426889DPR
CSB-BP426889DPR
CSB-MP426889DPR
CSB-EP426889DPR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Azorhizobium caulinodans UDP-3-O-acylglucosamine N-acyltransferase (lpxD) CSB-YP426890DPR
CSB-EP426890DPR
CSB-BP426890DPR
CSB-MP426890DPR
CSB-EP426890DPR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Azorhizobium caulinodans Chorismate synthase (aroC) CSB-YP426891DPR
CSB-EP426891DPR
CSB-BP426891DPR
CSB-MP426891DPR
CSB-EP426891DPR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Azorhizobium caulinodans Fructose-1,6-bisphosphatase class 1 (fbp) CSB-YP426892DPR
CSB-EP426892DPR
CSB-BP426892DPR
CSB-MP426892DPR
CSB-EP426892DPR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Azorhizobium caulinodans Bifunctional protein FolD (folD) CSB-YP426893DPR
CSB-EP426893DPR
CSB-BP426893DPR
CSB-MP426893DPR
CSB-EP426893DPR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Azorhizobium caulinodans Ribonuclease HII (rnhB) CSB-YP426894DPR
CSB-EP426894DPR
CSB-BP426894DPR
CSB-MP426894DPR
CSB-EP426894DPR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Azorhizobium caulinodans Indole-3-glycerol phosphate synthase (trpC) CSB-YP426895DPR
CSB-EP426895DPR
CSB-BP426895DPR
CSB-MP426895DPR
CSB-EP426895DPR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Azorhizobium caulinodans Glutamyl-tRNA (Gln) amidotransferase subunit A CSB-YP426896DPR
CSB-EP426896DPR
CSB-BP426896DPR
CSB-MP426896DPR
CSB-EP426896DPR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Azorhizobium caulinodans 30S ribosomal protein S11 (rpsK) CSB-YP426897DPR
CSB-EP426897DPR
CSB-BP426897DPR
CSB-MP426897DPR
CSB-EP426897DPR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>